|
BO35056 |
N-(1,3-benzothiazol-2-yl)-2-{[1-(3,4-dimethylphenyl)-4-oxo-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-6-yl]sulfanyl}acetamide |
851125-79-6 |
C22H18N6O2S2 |
462.5473 |
VIEW DETAILS > |
|
BO35064 |
1-tert-butyl-4-[(4-chlorophenyl)sulfanyl]-3-methyl-1H-pyrazol-5-yl 2-(3,4-dimethoxyphenyl)acetate |
851127-73-6 |
C24H27ClN2O4S |
475.0002 |
VIEW DETAILS > |
|
BO35065 |
N-[2-(4-methoxyphenyl)-2H,4H,6H-thieno[3,4-c]pyrazol-3-yl]adamantane-1-carboxamide |
361168-88-9 |
C23H27N3O2S |
409.5444 |
VIEW DETAILS > |
|
BO35066 |
2-{[(2-fluorophenyl)methyl]sulfanyl}-3-phenyl-3H,4H,5H-pyrimido[5,4-b]indol-4-one |
536704-16-2 |
C23H16FN3OS |
401.4560 |
VIEW DETAILS > |
|
BO35069 |
8,8-dimethyl-2-{[(4-nitrophenyl)methyl]sulfanyl}-5-(pyridin-4-yl)-3H,4H,5H,6H,7H,8H,9H,10H-pyrimido[4,5-b]quinoline-4,6-dione |
537044-92-1 |
C25H23N5O4S |
489.5462 |
VIEW DETAILS > |
|
BO35254 |
URAT1&XO inhibitor 1 |
2669726-78-5 |
C20H13N5O3S |
403.4139 |
VIEW DETAILS > |
|
BO35279 |
Aurora Kinases-IN-3 |
2840558-83-8 |
C20H16F3N3O4 |
419.3539 |
VIEW DETAILS > |
|
BO35282 |
MAO-A/5-HT2AR-IN-1 |
2769156-00-3 |
C30H28FN3O2 |
481.5606 |
VIEW DETAILS > |
|
BO35290 |
Smurf1-IN-1 |
1824708-03-3 |
C24H29ClN6O2 |
468.9791 |
VIEW DETAILS > |
|
BO35489 |
Fotagliptin benzoate |
1403496-40-1 |
C24H25FN6O3 |
464.4921 |
VIEW DETAILS > |